Transcription of HYPERSENSITIVITY REACTIONS (HSR) TO …
{{id}} {{{paragraph}}}
Risk minimisation material for Abacavir / lamivudine 1 HYPERSENSITIVITY REACTIONS (HSR) TO ABACAVIR / lamivudine Important risk minimisation material for Healthcare Professionals Risk minimisation material for Abacavir / lamivudine 2 Introduction Abacavir is a component of Abacavir / lamivudine In this combination product, HYPERSENSITIVITY REACTIONS are due to Abacavir. Therefore, subsequent slides frequently use the term Abacavir - HYPERSENSITIVITY REACTIONS (HSR) The information included in this educational material is in line with the Summary of Product Characteristics (SmPC) of Abacavir / lamivudine , Reference Listed Drug (Kivexa) and the SmPC of Abacavir This educational material is provided as part of the Risk Management Plans for Abacavir-containing medicines and is not intended to be promotional in nature Please refer to the SmPC before prescribing Abacavir / lamivudine For ytterligere informasjon se oppdatert preparatomtale (SPC) p Legemiddels k hos Risk minimisation material for Abacavir / lamivudine 3 Objectives of this Important risk minimisation mat
Risk minimisation material for Abacavir / Lamivudine 2 Introduction • Abacavir is a component of Abacavir / Lamivudine • In this combination product, hypersensitivity reactions are due to Abacavir.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}